MedTrace Logo

Translating The GOLD COPD Guidelines Into Primary Care Practice

NCT01237561 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3593

Last updated 2017-04-04

No results posted yet for this study

Summary

This project will evaluate the translation of the Gold (the Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease) COPD guidelines into primary care practice. During phase I, a needs assessment will evaluate barriers and facilitators to implementation of COPD guidelines into clinical practice through focus groups of primary care patients and providers. Using formative evaluation and feedback from the focus groups, three tools will be developed, refined and pilot tested. The effectiveness of the materials developed in phase I will be tested in phase II (a randomized clinical trial conducted with one year of intervention within non-academic primary care practices) regarding physician performance of COPD guideline implementation and improvement in the clinically relevant outcomes (appropriate screening, diagnosis and management of COPD) compared to usual care.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

OTHER

provider support tools plus spirometer

Patient Activation Tool, Provider Web-based decision support tool, academic detailing

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Memorial Hospital of Rhode Island

    lead OTHER

Principal Investigators

  • Donna R Parker, Sc.D. · MHRhode Island

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2013-10-25
Completion
2013-10-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01237561 on ClinicalTrials.gov